Shares of Swiss pharmaceuticals company Novartis saw its share price climb higher on Tuesday after it reported its third quarter earnings report. The company saw its net income rise 7% in the quarter, citing the growth of Cosentyx, its psoriasis treatment, as well as its eye care business and some cancer drugs. For the period, … Continue reading “Novartis Climbs Higher After Earnings Rise”
Author: Sophia Vida
This Guy Thinks Bitcoin is “Enron in the Making”
According to Prince Alwaleed, a Saudi billionaire, the bitcoin rally will not last forever. The…
AMD to Tank Over 60% For This Reason
According to Citi Research, AMD shares are going to fall. The firm, which just reiterated…
Sprint and T-Mobile Could Announce Deal Next Month
According to sources familiar with the situation who spoke to CNBC, T-Mobile and Sprint could…
You Can Now Use PayPal on Facebook Messenger
A lot of people were very excited to learn on Friday that they can now…
Julia Louis-Dreyfus Fights Breast Cancer with a Roar
Former Seinfeld star who currently stars on Veep, Julia Louis-Dreyfus, is battling breast cancer, but…
General Electric Shares Collapsed but Soared Back After This
General Electric just released its third quarter earnings report and Wall Street wasn't too thrilled.…
Gilead Shares Move Higher After FDA Approves its Cancer Drug
Gilead made an excellent move acquiring Kite Pharma because a drug that Kite developed has…
Playboy Just Made History By Naming First Transgender Playmate
A French model has made history by becoming the very first transgender playmate for famed…
Blue Apron Will Be Slashing 6% of its Workforce
It's been a rocky few months for Blue Apron ever since it made its public…
Snapchat Just Signed an Olympic Deal With This Company
It was an exciting day for Snapchat on Wednesday. It was revealed that the social…
Bank of America Downgrades Chipotle For This Reason
Chipotle was given a downgrade this week by Bank of America Merrill Lynch, and for…
Merck Shares Explode After Citi Upgrade
It was a strong day for pharmaceutical company Merck on Wednesday. The stock's shares started…
You May Not Believe How Cheap LeBron James Is
LeBron James is arguably one of the best NBA players and one of the highest…
